Matrivax, Inc.

Boston, Massachusetts, United States
Purpose
to apply a novel, cost-reducing technology which entraps many polysaccharide antigens in a protein matrix. If successful, this prototype platform could increase the breadth of serotypes currently covered by pneumococcal vaccines
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
12
Grantee location
Boston, Massachusetts, United States
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.